CD200 and infection: In vivo blocking significantly (p = 0.0027) reduced parasite burden 4 weeks post infection in α-CD200 antibody-treated animals as compared to naïve infected that further confirmed the protective capabilities of CD200 blocking (Figure S5 in Supplementary Material).